KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.
Identifieur interne : 000448 ( Main/Exploration ); précédent : 000447; suivant : 000449KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.
Auteurs : Mark J. Sarnak [États-Unis] ; Roy Bloom [États-Unis] ; Paul Muntner [États-Unis] ; Mahboob Rahman [États-Unis] ; Jeffrey M. Saland [États-Unis] ; Peter W F. Wilson [États-Unis] ; Linda Fried [États-Unis]Source :
- American journal of kidney diseases : the official journal of the National Kidney Foundation [ 1523-6838 ] ; 2015.
Descripteurs français
- KwdFr :
- Dyslipidémies (), Dyslipidémies (diagnostic), Dyslipidémies (sang), Guides de bonnes pratiques cliniques comme sujet (normes), Humains, Insuffisance rénale chronique (), Insuffisance rénale chronique (diagnostic), Insuffisance rénale chronique (sang), Lipides (sang), Prise en charge de la maladie, Résultat thérapeutique.
- MESH :
English descriptors
- KwdEn :
- MESH :
- chemical , blood : Lipids.
- blood : Dyslipidemias, Renal Insufficiency, Chronic.
- diagnosis : Dyslipidemias, Renal Insufficiency, Chronic.
- standards : Practice Guidelines as Topic.
- therapy : Dyslipidemias, Renal Insufficiency, Chronic.
- Disease Management, Humans, Treatment Outcome.
Abstract
The National Kidney Foundation-Kidney Disease Outcomes Quality Initiative (NKF-KDOQI) guideline for management of dyslipidemia in chronic kidney disease (CKD) was published in 2003. Since then, considerable evidence, including randomized controlled trials of statin therapy in adults with CKD, has helped better define medical treatments for dyslipidemia. In light of the new evidence, KDIGO (Kidney Disease: Improving Global Outcomes) formed a work group for the management of dyslipidemia in patients with CKD. This work group developed a new guideline that contains substantial changes from the prior KDOQI guideline. KDIGO recommends treatment of dyslipidemia in patients with CKD primarily based on risk for coronary heart disease, which is driven in large part by age. The KDIGO guideline does not recommend using low-density lipoprotein cholesterol level as a guide for identifying individuals with CKD to be treated or as treatment targets. Initiation of statin treatment is no longer recommended in dialysis patients. To assist US practitioners in interpreting and applying the KDIGO guideline, NKF-KDOQI convened a work group to write a commentary on this guideline. For the most part, our work group agreed with the recommendations of the KDIGO guideline, although we describe several areas in which we believe the guideline statements are either too strong or need to be more nuanced, areas of uncertainty and inconsistency, as well as additional research recommendations. The target audience for the KDIGO guideline includes nephrologists, primary care practitioners, and non-nephrology specialists such as cardiologists and endocrinologists. As such, we also put the current recommendations into the context of other clinical practice recommendations for cholesterol treatment.
DOI: 10.1053/j.ajkd.2014.10.005
PubMed: 25465166
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000443
- to stream PubMed, to step Curation: 000443
- to stream PubMed, to step Checkpoint: 000443
- to stream Ncbi, to step Merge: 004221
- to stream Ncbi, to step Curation: 004221
- to stream Ncbi, to step Checkpoint: 004221
- to stream Main, to step Merge: 000448
- to stream Main, to step Curation: 000448
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.</title><author><name sortKey="Sarnak, Mark J" sort="Sarnak, Mark J" uniqKey="Sarnak M" first="Mark J" last="Sarnak">Mark J. Sarnak</name><affiliation wicri:level="2"><nlm:affiliation>Tufts University School of Medicine, Boston, MA. Electronic address: msarnak@tuftsmedicalcenter.org.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>Tufts University School of Medicine, Boston</wicri:cityArea></affiliation></author><author><name sortKey="Bloom, Roy" sort="Bloom, Roy" uniqKey="Bloom R" first="Roy" last="Bloom">Roy Bloom</name><affiliation wicri:level="2"><nlm:affiliation>University of Pennsylvania, Philadelphia, PA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>University of Pennsylvania, Philadelphia</wicri:cityArea></affiliation></author><author><name sortKey="Muntner, Paul" sort="Muntner, Paul" uniqKey="Muntner P" first="Paul" last="Muntner">Paul Muntner</name><affiliation wicri:level="2"><nlm:affiliation>University of Alabama, Birmingham, AL.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Alabama</region></placeName><wicri:cityArea>University of Alabama, Birmingham</wicri:cityArea></affiliation></author><author><name sortKey="Rahman, Mahboob" sort="Rahman, Mahboob" uniqKey="Rahman M" first="Mahboob" last="Rahman">Mahboob Rahman</name><affiliation wicri:level="2"><nlm:affiliation>Case Western University, Cleveland, OH.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Ohio</region></placeName><wicri:cityArea>Case Western University, Cleveland</wicri:cityArea></affiliation></author><author><name sortKey="Saland, Jeffrey M" sort="Saland, Jeffrey M" uniqKey="Saland J" first="Jeffrey M" last="Saland">Jeffrey M. Saland</name><affiliation wicri:level="2"><nlm:affiliation>Icahn School of Medicine at Mt. Sinai, NY, NY.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Icahn School of Medicine at Mt. Sinai, NY</wicri:cityArea></affiliation></author><author><name sortKey="Wilson, Peter W F" sort="Wilson, Peter W F" uniqKey="Wilson P" first="Peter W F" last="Wilson">Peter W F. Wilson</name><affiliation wicri:level="2"><nlm:affiliation>Emory University School of Medicine, Atlanta, GA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Géorgie (États-Unis)</region></placeName><wicri:cityArea>Emory University School of Medicine, Atlanta</wicri:cityArea></affiliation></author><author><name sortKey="Fried, Linda" sort="Fried, Linda" uniqKey="Fried L" first="Linda" last="Fried">Linda Fried</name><affiliation wicri:level="2"><nlm:affiliation>University of Pittsburgh, Pittsburgh, PA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>University of Pittsburgh, Pittsburgh</wicri:cityArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25465166</idno><idno type="pmid">25465166</idno><idno type="doi">10.1053/j.ajkd.2014.10.005</idno><idno type="wicri:Area/PubMed/Corpus">000443</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000443</idno><idno type="wicri:Area/PubMed/Curation">000443</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000443</idno><idno type="wicri:Area/PubMed/Checkpoint">000443</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000443</idno><idno type="wicri:Area/Ncbi/Merge">004221</idno><idno type="wicri:Area/Ncbi/Curation">004221</idno><idno type="wicri:Area/Ncbi/Checkpoint">004221</idno><idno type="wicri:Area/Main/Merge">000448</idno><idno type="wicri:Area/Main/Curation">000448</idno><idno type="wicri:Area/Main/Exploration">000448</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.</title><author><name sortKey="Sarnak, Mark J" sort="Sarnak, Mark J" uniqKey="Sarnak M" first="Mark J" last="Sarnak">Mark J. Sarnak</name><affiliation wicri:level="2"><nlm:affiliation>Tufts University School of Medicine, Boston, MA. Electronic address: msarnak@tuftsmedicalcenter.org.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>Tufts University School of Medicine, Boston</wicri:cityArea></affiliation></author><author><name sortKey="Bloom, Roy" sort="Bloom, Roy" uniqKey="Bloom R" first="Roy" last="Bloom">Roy Bloom</name><affiliation wicri:level="2"><nlm:affiliation>University of Pennsylvania, Philadelphia, PA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>University of Pennsylvania, Philadelphia</wicri:cityArea></affiliation></author><author><name sortKey="Muntner, Paul" sort="Muntner, Paul" uniqKey="Muntner P" first="Paul" last="Muntner">Paul Muntner</name><affiliation wicri:level="2"><nlm:affiliation>University of Alabama, Birmingham, AL.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Alabama</region></placeName><wicri:cityArea>University of Alabama, Birmingham</wicri:cityArea></affiliation></author><author><name sortKey="Rahman, Mahboob" sort="Rahman, Mahboob" uniqKey="Rahman M" first="Mahboob" last="Rahman">Mahboob Rahman</name><affiliation wicri:level="2"><nlm:affiliation>Case Western University, Cleveland, OH.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Ohio</region></placeName><wicri:cityArea>Case Western University, Cleveland</wicri:cityArea></affiliation></author><author><name sortKey="Saland, Jeffrey M" sort="Saland, Jeffrey M" uniqKey="Saland J" first="Jeffrey M" last="Saland">Jeffrey M. Saland</name><affiliation wicri:level="2"><nlm:affiliation>Icahn School of Medicine at Mt. Sinai, NY, NY.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Icahn School of Medicine at Mt. Sinai, NY</wicri:cityArea></affiliation></author><author><name sortKey="Wilson, Peter W F" sort="Wilson, Peter W F" uniqKey="Wilson P" first="Peter W F" last="Wilson">Peter W F. Wilson</name><affiliation wicri:level="2"><nlm:affiliation>Emory University School of Medicine, Atlanta, GA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Géorgie (États-Unis)</region></placeName><wicri:cityArea>Emory University School of Medicine, Atlanta</wicri:cityArea></affiliation></author><author><name sortKey="Fried, Linda" sort="Fried, Linda" uniqKey="Fried L" first="Linda" last="Fried">Linda Fried</name><affiliation wicri:level="2"><nlm:affiliation>University of Pittsburgh, Pittsburgh, PA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>University of Pittsburgh, Pittsburgh</wicri:cityArea></affiliation></author></analytic><series><title level="j">American journal of kidney diseases : the official journal of the National Kidney Foundation</title><idno type="eISSN">1523-6838</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Disease Management</term><term>Dyslipidemias (blood)</term><term>Dyslipidemias (diagnosis)</term><term>Dyslipidemias (therapy)</term><term>Humans</term><term>Lipids (blood)</term><term>Practice Guidelines as Topic (standards)</term><term>Renal Insufficiency, Chronic (blood)</term><term>Renal Insufficiency, Chronic (diagnosis)</term><term>Renal Insufficiency, Chronic (therapy)</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Dyslipidémies ()</term><term>Dyslipidémies (diagnostic)</term><term>Dyslipidémies (sang)</term><term>Guides de bonnes pratiques cliniques comme sujet (normes)</term><term>Humains</term><term>Insuffisance rénale chronique ()</term><term>Insuffisance rénale chronique (diagnostic)</term><term>Insuffisance rénale chronique (sang)</term><term>Lipides (sang)</term><term>Prise en charge de la maladie</term><term>Résultat thérapeutique</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Lipids</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Dyslipidemias</term><term>Renal Insufficiency, Chronic</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Dyslipidemias</term><term>Renal Insufficiency, Chronic</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Dyslipidémies</term><term>Insuffisance rénale chronique</term></keywords><keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Guides de bonnes pratiques cliniques comme sujet</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Dyslipidémies</term><term>Insuffisance rénale chronique</term><term>Lipides</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Practice Guidelines as Topic</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Dyslipidemias</term><term>Renal Insufficiency, Chronic</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Disease Management</term><term>Humans</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Dyslipidémies</term><term>Humains</term><term>Insuffisance rénale chronique</term><term>Prise en charge de la maladie</term><term>Résultat thérapeutique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The National Kidney Foundation-Kidney Disease Outcomes Quality Initiative (NKF-KDOQI) guideline for management of dyslipidemia in chronic kidney disease (CKD) was published in 2003. Since then, considerable evidence, including randomized controlled trials of statin therapy in adults with CKD, has helped better define medical treatments for dyslipidemia. In light of the new evidence, KDIGO (Kidney Disease: Improving Global Outcomes) formed a work group for the management of dyslipidemia in patients with CKD. This work group developed a new guideline that contains substantial changes from the prior KDOQI guideline. KDIGO recommends treatment of dyslipidemia in patients with CKD primarily based on risk for coronary heart disease, which is driven in large part by age. The KDIGO guideline does not recommend using low-density lipoprotein cholesterol level as a guide for identifying individuals with CKD to be treated or as treatment targets. Initiation of statin treatment is no longer recommended in dialysis patients. To assist US practitioners in interpreting and applying the KDIGO guideline, NKF-KDOQI convened a work group to write a commentary on this guideline. For the most part, our work group agreed with the recommendations of the KDIGO guideline, although we describe several areas in which we believe the guideline statements are either too strong or need to be more nuanced, areas of uncertainty and inconsistency, as well as additional research recommendations. The target audience for the KDIGO guideline includes nephrologists, primary care practitioners, and non-nephrology specialists such as cardiologists and endocrinologists. As such, we also put the current recommendations into the context of other clinical practice recommendations for cholesterol treatment.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Alabama</li><li>Géorgie (États-Unis)</li><li>Massachusetts</li><li>Ohio</li><li>Pennsylvanie</li><li>État de New York</li></region></list><tree><country name="États-Unis"><region name="Massachusetts"><name sortKey="Sarnak, Mark J" sort="Sarnak, Mark J" uniqKey="Sarnak M" first="Mark J" last="Sarnak">Mark J. Sarnak</name></region><name sortKey="Bloom, Roy" sort="Bloom, Roy" uniqKey="Bloom R" first="Roy" last="Bloom">Roy Bloom</name><name sortKey="Fried, Linda" sort="Fried, Linda" uniqKey="Fried L" first="Linda" last="Fried">Linda Fried</name><name sortKey="Muntner, Paul" sort="Muntner, Paul" uniqKey="Muntner P" first="Paul" last="Muntner">Paul Muntner</name><name sortKey="Rahman, Mahboob" sort="Rahman, Mahboob" uniqKey="Rahman M" first="Mahboob" last="Rahman">Mahboob Rahman</name><name sortKey="Saland, Jeffrey M" sort="Saland, Jeffrey M" uniqKey="Saland J" first="Jeffrey M" last="Saland">Jeffrey M. Saland</name><name sortKey="Wilson, Peter W F" sort="Wilson, Peter W F" uniqKey="Wilson P" first="Peter W F" last="Wilson">Peter W F. Wilson</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000448 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000448 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25465166
|texte= KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25465166" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a PittsburghV1
| This area was generated with Dilib version V0.6.38. |  |